MedPath

江苏海宏制药有限公司

Ownership
-
Established
2008-01-29
Employees
-
Market Cap
-
Website
https://www.china-haihong.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

NMPA:31

Drug Approvals

Mezlocillin sodium and Sulbactam sodium for Injection

Product Name
注射用美洛西林钠舒巴坦钠
Approval Number
国药准字H20183506
Approval Date
Oct 25, 2023
NMPA

Mezlocillin sodium and Sulbactam sodium for Injection

Product Name
注射用美洛西林钠舒巴坦钠
Approval Number
国药准字H20183505
Approval Date
Oct 25, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20130131
Approval Date
Jul 13, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20173073
Approval Date
Jul 13, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20130130
Approval Date
Jul 13, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20073788
Approval Date
Mar 8, 2022
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20073789
Approval Date
Mar 8, 2022
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20073787
Approval Date
Mar 8, 2022
NMPA

Azlocillin Sodium for Injection

Product Name
注射用阿洛西林钠
Approval Number
国药准字H20056581
Approval Date
Jul 24, 2020
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20067999
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.